Please sign in to follow a disease.
Laughter may be the best medicine for COPD breathlessness
NCT ID NCT05997550
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether pursed lip breathing exercises and laughter therapy can reduce shortness of breath, improve health status, and lower care dependence in people with chronic obstructive pulmonary disease (COPD). 63 adults with COPD were split into three groups: one did breathing exercises, one did laughter therapy, and one received standard education. The interventions lasted 8 weeks, and symptoms were measured at 4, 8, and 12 weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- pursed lip breathing exercise and laughter therapy
- What this could lead to
- If it works, this could offer simple, drug-free ways to help people with COPD feel less breathless and more independent.
- What could go wrong
- This is a small, completed study with only 63 participants. The results may not apply to everyone with COPD, and the benefits might be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
63 people
The number who actually took part.
- Started
-
Aug 2022
- Finished
-
Oct 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Those aged 40 and over, * He was diagnosed with COPD as a result of medical history, physical examination and pulmonary function tests, and his CAT score is 10 and above according to the COPD Unified Assessment\* of the GOLD guide; In Group B and D (1), * There is no diagnosis of a disease that may affect the cognitive state, * Not having a diagnosis of a physical or mental illness that will prevent communication, and able to use a telephone. * Individuals who agree to participate in the research are included in the study Non-Inclusion Criteria: Those who have difficulty in verbal communication (intubation, tracheostomy, delirium, etc.) * With a CAT score of less than 10 and in Groups A and C according to the COPD Combined Assessment\* of the GOLD guide, * Having a disorder that disrupts the cognitive process such as schizophrenia or dementia * Alcohol, substance addiction, * Laughter therapy was not deemed appropriate due to the diagnosis of abdominal surgery, uncontrolled hypertension, glaucoma, abdominal hernia, epilepsy in the last three months, * Using complementary and integrative treatments such as acupuncture, meditation, yoga, massage, relaxation exercises, * Patients who do not agree to participate in the study are excluded from the study. Exclusion criteria * Not complying with pursed lip breathing exercise and laughter therapy and program, * Developing a disease that may affect the health status or a condition requiring hospitalization (COPD exacerbation, etc.) during the 12-week period during which the research will take place, * Changes in bronchodilator and oxygen therapy regimens, * A situation that is not suitable for laughter therapy due to the diagnosis of surgery in the abdominal region, uncontrollable hypertension, glaucoma, abdominal hernia, epilepsy, * Patients who want to withdraw from the study are excluded from the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bilkent City Hospital
Ankara, Çamlıca Mahallesi, 06520, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can zapping the Brain's diaphragm center help COPD breathing?
- Can a COPD flare stun the heart? study watches for hidden strain
- Can better training get doctors to talk about what matters most to dying veterans?
- Can an injected antibody calm inflamed lungs and cut COPD flare-ups?
- Detailed lung scans could map COPD damage more precisely
- Can AI help nurses guide At-Risk seniors to better care and lower costs?